The main objective of Translational Oncologic Pathology Services (TOPS) is to provide an end-to-end solution that consolidates multiple pathology-related services into a single infrastructure. This consolidation improves our investigators and collaborators’ experience by facilitating equitable access, producing high-quality biospecimens, maximizing biospecimen utility, and providing essential education on the appropriate use and interpretation of biospecimens.
Key Personnel:
Aatur Singhi, MD, PhD
Devin Dressman, PhD
Maureen Lyons, MS
Kate Smith, BA
Acknowledgement:
Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number P30CA047904 and the UPMC Hillman Cancer Center Translational Oncologic Pathology Services (TOPS).
